A step in the right direction: the evidence for treating of tinea pedis and onychomycosis in people with diabetes
2011

Treating Foot Infections in Diabetic Patients

publication Evidence: low

Author Information

Author(s): Matricciani Lisa, Talbot Kerwin, Jones Sara

Primary Institution: University of South Australia

Hypothesis

What evidence is there for antifungal treatment interventions for adults with tinea pedis and/or onychomycosis in people with diabetes?

Conclusion

Further research is needed to determine the best treatment options for foot infections in diabetic patients.

Supporting Evidence

  • Most studies on antifungal treatments exclude patients with diabetes.
  • Seven studies were identified, all focusing on onychomycosis treatments.
  • Topical ciclopirox, oral terbinafine, and oral itraconazole were found safe and effective.

Takeaway

This study found that there aren't many studies on treating foot infections in people with diabetes, and more research is needed to find the best treatments.

Methodology

A systematic literature search of four electronic databases was conducted to find studies on antifungal treatments for diabetes patients.

Limitations

There is a scarcity of studies specifically investigating antifungal treatments for tinea pedis in patients with diabetes.

Participant Demographics

Adults with diabetes.

Digital Object Identifier (DOI)

10.1186/1757-1146-4-S1-P34

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication